Company / Shares Outstanding
C4 Therapeutics, Inc. Shares Outstanding History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
70.6M
FY2025
5-year range
48.7M / 70.6M
FY2022-FY2025
Trend
+16.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has increased for 3 consecutive years, from 48688875.00 in FY2022 to 70625899.00 in FY2025.
Based on SEC 10-K filings.
70625899.00 in FY2025 with a 3-year CAGR of +13.2%.
Increased from 48966216.00 to 70625899.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +13.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- C4 Therapeutics, Inc.'s shares outstanding has grown for 3 consecutive years.
- In FY2025, shares outstanding increased 16.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 70.6M | +16.8% |
| FY2024 | 60.5M | +23.5% |
| FY2023 | 49.0M | +0.6% |
| FY2022 | 48.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026